000 | 01427 a2200397 4500 | ||
---|---|---|---|
005 | 20250516115221.0 | ||
264 | 0 | _c20121217 | |
008 | 201212s 0 0 eng d | ||
022 | _a1545-861X | ||
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aMultistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy - United States, 2012. _h[electronic resource] |
260 |
_bMMWR. Morbidity and mortality weekly report _cOct 2012 |
||
300 |
_a839-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aAspergillus fumigatus _xisolation & purification |
650 | 0 | 4 | _aCenters for Disease Control and Prevention, U.S. |
650 | 0 | 4 | _aDisease Outbreaks |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aDrug Contamination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Epidural |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMeningitis, Fungal _xcomplications |
650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
650 | 0 | 4 | _aMethylprednisolone Acetate |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPharmacies |
650 | 0 | 4 |
_aUnited States _xepidemiology |
650 | 0 | 4 | _aYoung Adult |
773 | 0 |
_tMMWR. Morbidity and mortality weekly report _gvol. 61 _gno. 41 _gp. 839-42 |
|
999 |
_c22192879 _d22192879 |